Description

The global bone grafts and substitutes market is set to increase by US$ 3.4 billion from 2022 to 2028, representing a compound annual growth rate (CAGR) of 6.7% during the forecast period.

The report provides up-to-date market size data for period 2018-2021 and forecast to 2028 covering key market aspects like sales value for bone grafts and substitutes. The global bone grafts and substitutes market is segmented on the basis of product, application, and region. On the basis of product, the global bone grafts and substitutes market has been segmented into natural bone grafts, synthetic bone substitutes. Among these, the natural bone grafts segment was accounted for the highest revenue generator in 2021. By application, the global bone grafts and substitutes market has been segmented into craniomaxillofacial, dental, joint reconstruction, spinal fusion, others. In terms of geography, the global bone grafts and substitutes market has been segmented into Asia Pacific, Europe, North America, Rest of the World (RoW). North America held the largest share of the global bone grafts and substitutes market in 2021 and is anticipated to hold its share during the forecast period.

The synthetic bone substitutes market is further segmented into bone substitutes with living cells, composite bone substitute, and growth factor substitutes. The composite bone substitute segment captured the largest share of the market in 2021 and is expected to maintain its dominance during the forecast period. Furthermore, the natural bone grafts market has been categorized into allograft, autograft, phytogenic materials, and xenograft. According to the research, the autograft segment had the largest share in the global bone grafts and substitutes market.

The global bone grafts and substitutes market is highly competitive. Some of the leading companies operating in the market are AlloSource Inc., Anika Therapeutics Inc., Dentsply Sirona Inc., Globus Medical Inc., Institut Straumann AG, Integra LifeSciences Holdings Corporation, Johnson & Johnson, Patterson Companies Inc., Seaspine Inc., Zimmer Biomet Holdings Inc. Competitive landscape gives a description of the competitive nature of the global bone grafts and substitutes market and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.

The report is an invaluable resource for companies and organizations active in this industry. It provides a cohesive picture of the bone grafts and substitutes market to help drive informed decision making for industry executives, policy makers, academic, and analysts.

Report Scope

Product: natural bone grafts, synthetic bone substitutes
Application: craniomaxillofacial, dental, joint reconstruction, spinal fusion, others
Region: Asia Pacific, Europe, North America, Rest of the World (RoW)
Years considered: this report covers the period 2018 to 2028
Company mentioned: AlloSource Inc., Anika Therapeutics Inc., Dentsply Sirona Inc., Globus Medical Inc., Institut Straumann AG, Integra LifeSciences Holdings Corporation, Johnson & Johnson, Patterson Companies Inc., Seaspine Inc., Zimmer Biomet Holdings Inc.

Key Benefits for Stakeholders

– Get a comprehensive picture of the global bone grafts and substitutes market
– Pinpoint growth sectors and trends for investment

Table of Contents

Part 1. Introduction
– Scope of the study
– Study period
– Geographical scope
– Research methodology
Part 2. Bone grafts and substitutes market overview
Part 3. Market breakdown by product
– Natural bone grafts
– Synthetic bone substitutes
Part 4. Market breakdown by application
– Craniomaxillofacial
– Dental
– Joint reconstruction
– Spinal fusion
– Others
Part 5. Market breakdown by region
– Asia Pacific
– Europe
– North America
– Rest of the World (RoW)
Part 6. Key companies
– AlloSource Inc.
– Anika Therapeutics Inc.
– Dentsply Sirona Inc.
– Globus Medical Inc.
– Institut Straumann AG
– Integra LifeSciences Holdings Corporation
– Johnson & Johnson
– Patterson Companies Inc.
– Seaspine Inc.
– Zimmer Biomet Holdings Inc.
About StrategyHelix
Disclaimer